
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
SNAP47 CRISPR/Cas9 KO Plasmid (h) | sc-410264 | 20 µg | $397.00 |
SNAP47 encodes a SNAP receptor (SNARE) family protein that participates in vesicle docking and membrane fusion by engaging cognate syntaxins and VAMPs to regulate exocytosis and endomembrane trafficking. It has been implicated in specialized secretory pathways, including neurotransmitter release and regulated cargo delivery, linking SNAP47 activity to synaptic vesicle cycling, membrane recycling, and spatial control of protein localization. Through its role in SNARE complex dynamics, SNAP47 influences cellular processes such as neurite outgrowth, receptor trafficking, and stimulus-coupled secretion. Dysregulated vesicle trafficking and synaptic signaling are relevant to neurodevelopmental and neurodegenerative research contexts, making SNAP47 a useful target for interrogating transport-dependent phenotypes.
SNAP47 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the SNAP47 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the SNAP47 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the SNAP47 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish SNAP47 protein expression.
This CRISPR knockout system enables efficient generation of SNAP47-deficient cell models for investigation of SNAP47 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.